China Slams U.S. for Sabotaging Trust in Its COVID Vaccines
In a significant diplomatic clash, the Chinese Embassy in the Philippines has accused the United States of conducting a covert…
Global Healthcare
Read More
Tackling the E. coli Outbreak in the UK: Causes, Symptoms, and Prevention
Recently, the UK has experienced a significant E.coli outbreak, prompting the recall of over 60 types of prepacked sandwiches, wraps,…
Bharat Biotech’s Rotavirus Vaccine Safety Under Scrutiny: A Detailed Analysis
Recent concerns have surfaced regarding the safety of Bharat Bio tech’s Rotavac, an indigenous rotavirus vaccine included in India’s national…
Staggering Drop in Medical Device Prices Since Pandemic
A recent report by Datawise reveals a substantial decrease in the prices of key medical devices since the pandemic, leading…
Japan Battles Deadly Surge of Flesh-Eating Bacteria After Post-COVID
Japan Faces Rising Cases of Deadly Streptococcal Toxic Shock Syndrome A surge in cases of a rare but lethal flesh-eating…
Rare Drug-Resistant Flu Variant Identified in the US, CDC Reports
Emergence of a Dual Mutant Flu Variant A rare influenza variant exhibiting resistance to oseltamivir phosphate, commonly known by its…
World Blood Donor Day 2024: 20 Years of Celebrating Giving: Thank You, Blood Donors!
World Blood Donor Day, observed annually on June 14th, marks its 20th anniversary in 2024. This global event, established by…
South Africa Records First Mpox Fatality: Health Minister Confirms
South Africa has reported its first death from Mpox Virus, formerly known as monkeypox, as confirmed by Health Minister Joe…
WHO Report Identifies Four Major Industries as Catalysts for 2.7 Million Deaths Annually in Europe
Industry Giants Accused of Prioritizing Profit Over Public Health In a damning report released by the World Health Organization (WHO)…
Game-Changing Dual Vaccine Crushes Influenza and COVID-19: Phase 3 Triumph Unveils Remarkable Breakthrough, Sparking Medical Revolution
CAMBRIDGE, MA / ACCESSWIRE / June 10, 2024 – Moderna, Inc. (NASDAQ:MRNA) has unveiled exciting news regarding its Phase 3…